Numan has added to its digital health stable with the acquisition of Sweden’s Vi Health and its suite of tools including an artificial intelligence-powered symptom checker.
UK-based men's health specialist Numan has received a $20 million cash injection from investor Kreos Health, which will be used to extend its digital health platform in Europe and expand th
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.